B28Safety of Lanreotide 120 mg ATG in combination with...

B28Safety of Lanreotide 120 mg ATG in combination with metformin in patients with progressive advanced well-differentiated gastro-intestinal (GI) or lung carcinoids. A pilot, one-arm, open-label, prospective study: the MetNET-2 trial

Buzzoni, R., Filippo, D.B., Femia, D., Prinzi, N., Concas, L., Milione, M., Tamborini, E., Perrone, F., Lo Russo, G., Vernieri, C., Pulice, I., Piras, F., Dinoi, G., Pusceddu, S.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
27
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw333.28
Date:
September, 2016
File:
PDF, 63 KB
2016
Conversion to is in progress
Conversion to is failed